BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1657988)

  • 41. Modulation of thyroid hormone action by mutant thyroid hormone receptors, c-erbA alpha 2 and peroxisome proliferator-activated receptor: evidence for different mechanisms of inhibition.
    Meier-Heusler SC; Zhu X; Juge-Aubry C; Pernin A; Burger AG; Cheng SY; Meier CA
    Mol Cell Endocrinol; 1995 Jan; 107(1):55-66. PubMed ID: 7796935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An exonic splicing silencer is involved in the regulated splicing of glucose 6-phosphate dehydrogenase mRNA.
    Szeszel-Fedorowicz W; Talukdar I; Griffith BN; Walsh CM; Salati LM
    J Biol Chem; 2006 Nov; 281(45):34146-58. PubMed ID: 16980303
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased messenger RNA levels of the antagonist thyroid hormone receptor erbA-alpha 2 and decreased levels of erbA-alpha 1 and erbA-beta 1 receptor messenger RNAs in neoplastic rodent cells.
    Too CK; Guernsey DL
    Cancer Res; 1992 Apr; 52(8):2186-90. PubMed ID: 1559222
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thyroid hormone receptor and receptor-related RNA levels in developing rat brain.
    North D; Fisher DA
    Pediatr Res; 1990 Dec; 28(6):622-5. PubMed ID: 1704499
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human carboxyl-terminal variant of alpha-type c-erbA inhibits trans-activation by thyroid hormone receptors without binding thyroid hormone.
    Lazar MA; Hodin RA; Chin WW
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):7771-4. PubMed ID: 2554288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Restriction and complexity of Mcf2 proto-oncogene expression.
    Galland F; Pirisi V; de Lapeyriere O; Birnbaum D
    Oncogene; 1991 May; 6(5):833-9. PubMed ID: 2052360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional domains of the v-erbA protein necessary for oncogenesis are required for transcriptional activation in Saccharomyces cerevisiae.
    Smit-McBride Z; Privalsky ML
    Oncogene; 1993 Jun; 8(6):1465-75. PubMed ID: 8099219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spliced leader RNAs from lower eukaryotes are trans-spliced in mammalian cells.
    Bruzik JP; Maniatis T
    Nature; 1992 Dec; 360(6405):692-5. PubMed ID: 1465136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reversal of aberrant splicing of beta-thalassemia allele by antisense RNA in vitro and in vivo.
    Zeng Y; Gu X; Chen Y; Gong L; Ren Z; Huang S
    Chin Med J (Engl); 1999 Feb; 112(2):107-11. PubMed ID: 11593572
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The strength of the HIV-1 3' splice sites affects Rev function.
    Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
    Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Specific regulation of mRNA splicing in vitro by a peptide from HIV-1 Rev.
    Kjems J; Frankel AD; Sharp PA
    Cell; 1991 Oct; 67(1):169-78. PubMed ID: 1913815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro splicing of cardiac troponin T precursors. Exon mutations disrupt splicing of the upstream intron.
    Cooper TA
    J Biol Chem; 1992 Mar; 267(8):5330-8. PubMed ID: 1544914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elements of the rat tropoelastin gene associated with alternative splicing.
    Pierce RA; Alatawi A; Deak SB; Boyd CD
    Genomics; 1992 Apr; 12(4):651-8. PubMed ID: 1572637
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing.
    Shkreta L; Bell B; Revil T; Venables JP; Prinos P; Elela SA; Chabot B
    Cancer Treat Res; 2013; 158():41-94. PubMed ID: 24222354
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antisense probes targeted to an internal domain in U2 snRNP specifically inhibit the second step of pre-mRNA splicing.
    Barabino SM; Sproat BS; Lamond AI
    Nucleic Acids Res; 1992 Sep; 20(17):4457-64. PubMed ID: 1408748
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Independent expression of the alpha and beta c-erbA genes in developing rat brain.
    Mellström B; Naranjo JR; Santos A; Gonzalez AM; Bernal J
    Mol Endocrinol; 1991 Sep; 5(9):1339-50. PubMed ID: 1663215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel models for RNA splicing that involve a small nuclear RNA.
    Ohshima Y; Itoh M; Okada N; Miyata T
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4471-4. PubMed ID: 6170064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proto-oncogene erbA expression and increased abundance of progesterone receptors in the mouse uterus after passive immunisation against progesterone before implantation.
    Whyte A; Wang MW; Cheng JT; Heap RB
    J Reprod Immunol; 1992 Aug; 22(2):153-72. PubMed ID: 1323675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alternative splicing in the neural cell adhesion molecule pre-mRNA: regulation of exon 18 skipping depends on the 5'-splice site.
    Tacke R; Goridis C
    Genes Dev; 1991 Aug; 5(8):1416-29. PubMed ID: 1869048
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA.
    Chung H ; Derse D
    J Biol Chem; 2001 Jun; 276(22):18960-7. PubMed ID: 11278454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.